Download PDF
Drug Res (Stuttg) 2015; 65(07): 354-360
DOI: 10.1055/s-0034-1384534
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Nitrosative Stress and Apoptosis by Intravenous Ferumoxytol, Iron Isomaltoside 1000, Iron Dextran, Iron Sucrose, and Ferric Carboxymaltose in a Nonclinical Model

J. E. Toblli
1   Laboratory of Experimental Medicine, Hospital Alemán, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
,
G. Cao
1   Laboratory of Experimental Medicine, Hospital Alemán, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
,
J. F. Giani
2   Instituto de Química y Fisicoquímica Biológica (UBA-CONICET), Facultad de Farmacia y Bioquímica, University of Buenos Aires, Buenos Aires, Argentina
,
F. P. Dominici
2   Instituto de Química y Fisicoquímica Biológica (UBA-CONICET), Facultad de Farmacia y Bioquímica, University of Buenos Aires, Buenos Aires, Argentina
,
M. Angerosa
1   Laboratory of Experimental Medicine, Hospital Alemán, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina
› Author Affiliations
Further Information

Publication History

received 28 February 2014

accepted 18 June 2014

Publication Date:
22 July 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Iron is involved in the formation as well as in the scavenging of reactive oxygen and nitrogen species. Thus, iron can induce as well as inhibit both oxidative and nitrosative stress. It also has a key role in reactive oxygen and nitrogen species-mediated apoptosis. We assessed the differences in tyrosine nitration and caspase 3 expression in the liver, heart, and kidneys of rats treated weekly with intravenous ferumoxytol, iron isomaltoside 1000, iron dextran, iron sucrose and ferric carboxymaltose (40 mg iron/kg body weight) for 5 weeks. Nitrotyrosine was quantified in tissue homogenates by Western blotting and the distribution of nitrotyrosine and caspase 3 was assessed in tissue sections by immunohistochemistry. Ferric carboxymaltose and iron sucrose administration did not result in detectable levels of nitrotyrosine or significant levels of caspase 3 vs. control in any of the tissue studied. Nitrotyrosine and caspase 3 levels were significantly (p<0.01) increased in all assessed organs of animals treated with iron dextran and iron isomaltoside 1000, as well as in the liver and kidneys of ferumoxytol-treated animals compared to isotonic saline solution (control). Nitrotyrosine and caspase 3 levels were shown to correlate positively with the amount of Prussian blue-detectable iron(III) deposits in iron dextran- and iron isomaltoside 1000-treated rats but not in ferumoxytol-treated rats, suggesting that iron dextran, iron isomaltoside 1000 and ferumoxytol induce nitrosative (and oxidative) stress as well as apoptosis via different mechanism(s).

Key words

caspase 3 - nitrotyrosine - rat
 

  • References

  • 1 Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258: 1898-1902
    CrossrefPubMedGoogle Scholar
  • 2 Forstermann U, Li H, Schwarz PM et al. NO synthesis and NOS regulation. In: Forman HJ, Fukuto JM, Torres M. (eds.) Signal transduction by reactive oxygen and nitrogen species: Pathways and chemical principles. Dordrecht: Kluwer Academic Publishers; 2003: 119-154
    Google Scholar
  • 3 Hill BG, Dranka BP, Bailey SM et al. What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. J Biol Chem 2010; 285: 19699-19704
    CrossrefPubMedGoogle Scholar
  • 4 Koskenkorva-Frank TS, Weiss G, Koppenol WH et al. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 2013; 65C: 1174-1194
    PubMedGoogle Scholar
  • 5 Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78: 931-936
    CrossrefPubMedGoogle Scholar
  • 6 Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424
    CrossrefPubMedGoogle Scholar
  • 7 Kim KM, Kim PK, Kwon YG et al. Regulation of apoptosis by nitrosative stress. J Biochem Mol Biol 2002; 35: 127-133
    CrossrefPubMedGoogle Scholar
  • 8 Virg L, Szabó É, Gergely P et al. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 2003; 140–141: 113-124
    PubMedGoogle Scholar
  • 9 Toblli JE, Cao G, Oliveri L et al. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model. Drug Res 2011; 61: 553-565
    PubMedGoogle Scholar
  • 10 Toblli JE, Cao G, Oliveri L et al. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model. Drug Res 2011; 61: 399-410
    PubMedGoogle Scholar
  • 11 Giani JF, Gironacci MM, Muñoz MC et al. Angiotensin-(1–7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am J Physiol Heart Circ Physiol 2007; 293: H1154-H1163
    CrossrefPubMedGoogle Scholar
  • 12 Muñoz MC, Argentino DP, Dominici FP et al. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens 2006; 24: 1607-1617
    CrossrefPubMedGoogle Scholar
  • 13 Toblli JE, Cao G, Olivieri L et al. Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrol Dial Transplant 2010; 25: 3631-3640
    CrossrefPubMedGoogle Scholar
  • 14 Cornejo P, Tapia G, Puntarulo S et al. Iron-induced changes in nitric oxide and superoxide radical generation in rat liver after lindane or thyroid hormone treatment. Toxicol Lett 2001; 119: 87-93
    CrossrefPubMedGoogle Scholar
  • 15 Lu N, Li X, Li J et al. Nitrative and oxidative modifications of enolase are associated with iron in iron-overload rats and in vitro. J Biol Inorg Chem 2011; 16: 481-490
    CrossrefPubMedGoogle Scholar
  • 16 Zhou XJ, Laszik Z, Wang XQ et al. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 2000; 80: 1905-1914
    CrossrefPubMedGoogle Scholar
  • 17 Bailie GR, Schuler C, Leggett RE et al. Oxidative effect of several intravenous iron complexes in the rat. Biometals 2013; 26: 473-478
    CrossrefPubMedGoogle Scholar
  • 18 Bouton C, Hirling H, Drapier JC. Redox modulation of iron regulatory proteins by peroxynitrite. J Biol Chem 1997; 272: 19969-19975
    CrossrefPubMedGoogle Scholar
  • 19 Galleano M, Simontacchi M, Puntarulo S. Nitric oxide and iron: effect of iron overload on nitric oxide production in endotoxemia. Mol Aspects Med 2004; 25: 141-154
    CrossrefPubMedGoogle Scholar
  • 20 Barbouti A, Amorgianiotis C, Kolettas E et al. Hydrogen peroxide inhibits caspase-dependent apoptosis by inactivating procaspase-9 in an iron-dependent manner. Free Radic Biol Med 2007; 43: 1377-1387
    CrossrefPubMedGoogle Scholar
  • 21 Kim YM, Chung HT, Simmons RL et al. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 2000; 275: 10954-10961
    CrossrefPubMedGoogle Scholar
  • 22 Sliskovic I, Mutus B. Reversible inhibition of caspase-3 activity by iron(III): potential role in physiological control of apoptosis. FEBS Lett 2006; 580: 2233-2237
    CrossrefPubMedGoogle Scholar
  • 23 Brunk UT, Neuzil J, Eaton JW. Lysosomal involvement in apoptosis. Redox Rep 2001; 6: 91-97
    CrossrefPubMedGoogle Scholar
  • 24 Henderson PA, Hillman RS. Characteristics of iron dextran utilization in man. Blood 1969; 34: 357-375
    PubMedGoogle Scholar
  • 25 Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol 2004; 15 (Suppl. 02) S93-S98
    PubMedGoogle Scholar
  • 26 Olsson KS, Weinfeld A. Availability of iron dextran for hemoglobin synthesis as studied with phlebotomy. Acta Med Scand 1972; 192: 543-549
    PubMedGoogle Scholar
  • 27 Kurz T, Terman A, Gustafsson B et al. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 2008; 129: 389-406
    CrossrefPubMedGoogle Scholar
  • 28 Kurz T, Eaton JW, Brunk UT. The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol 2011; 43: 1686-1697
    CrossrefPubMedGoogle Scholar
  • 29 Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 2004; 8: 445-454
    CrossrefPubMedGoogle Scholar
  • 30 Shiratori Y, Ohmura K, Hikiba Y et al. Hepatocyte nitric oxide production is induced by Kupffer cells. Dig Dis Sci 1998; 43: 1737-1745
    CrossrefPubMedGoogle Scholar
  • 31 Kim YM, Kim TH, Chung HT et al. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology 2000; 32: 770-778
    CrossrefPubMedGoogle Scholar
  • 32 Jahn MR, Andreasen HB, Fütterer S et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm 2011; 78: 480-491
    CrossrefPubMedGoogle Scholar
  • 33 Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 2012; 9: 20
    CrossrefPubMedGoogle Scholar
  • 34 Stern ST, Johnson DN. Role for nanomaterial-autophagy interaction in neurodegenerative disease. Autophagy 2008; 4: 1097-1100
    CrossrefPubMedGoogle Scholar